Rankings
▼
Calendar
IART Q2 2017 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena
IART
Integra LifeSciences Holdings Corporation
$747M
Q2 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$282M
+13.2% YoY
Gross Profit
$183M
64.9% margin
Operating Income
$17M
6.0% margin
Net Income
$11M
3.8% margin
EPS (Diluted)
$0.14
QoQ Revenue Growth
+9.1%
Cash Flow
Operating Cash Flow
$29M
Free Cash Flow
$16M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$2.1B
Total Liabilities
$1.2B
Stockholders' Equity
$895M
Cash & Equivalents
$155M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$282M
$249M
+13.2%
Gross Profit
$183M
$160M
+14.7%
Operating Income
$17M
$22M
-24.1%
Net Income
$11M
$13M
-15.1%
Revenue Segments
Specialty Surgical Solutions
$160M
57%
Orthopedics and Tissue Technologies
$122M
43%
Geographic Segments
UNITED STATES
$219M
78%
Europe
$32M
12%
Rest Of World
$30M
11%
← FY 2017
All Quarters
Q3 2017 →